1. Final Thoughts

   • Michael R. Hamrell

   Commentary 01 March 2011 Pages: 111 - 111

2. Editor’s Commentary: A Vision for the Journal’s Continued Growth

   • J. Rick Turner

   Commentary 01 March 2011 Pages: 113 - 117

3. The Promise and Progress of DIA 2011

   • Kenneth A. Getz

   Commentary 01 March 2011 Pages: 119 - 120

4. Medical Writing: Looking Back, Moving Forward

   • MaryAnn Foote

   Medical Writing 01 March 2011 Pages: 121 - 123

5. Topic-based Authoring: A Content Management Paradigm for Accurate, Consistent Regulatory Documents

   • Linda Fossati Wood
   • Michelle Herrera Foster
   • Nancy R. Katz

   Medical Writing 01 March 2011 Pages: 125 - 129

6. Little Red Riding Hood and the Big Bad Wolf Revisited as Structured Content

   • Linda Fossati Wood

   Medical Writing 01 March 2011 Pages: 131 - 135

7. Interpretation and Implementation of Good Publication Practice

   • Holly Brenza Zoog
   • Ting Chang

   Medical Writing 01 March 2011 Pages: 137 - 144

8. Publishing in Academia: Woes of Authorship, Figures, and Peer Review

   • Theodore R. Sadler

   Medical Writing 01 March 2011 Pages: 145 - 150

9. Enhancing the Clinical Professional’s Knowledge of Regulatory Documents

   • Sherri Bowen

   Medical Writing 01 March 2011 Pages: 151 - 154

10. Requirements for Biosimilars and Interchangeable Biological Drugs in the United States—in Plain Language

    • Suzanne M. Sensabaugh

    Regulatory Affairs 01 March 2011 Pages: 155 - 162

11. Some Controversial Issues in Clinical Trials

    • Shein-Chung Chow
    • Lan-Yon Yang
    • Ying Lu

    Regulatory Affairs 01 March 2011 Pages: 163 - 174

12. Assessment of Pharmaceutical Research and Development Productivity with a Novel Net Present Value-based Project Database

    • Shintaro Sengoku
    • Toshihide Yoda
    • Atsushi Seki

    Regulatory Affairs 01 March 2011 Pages: 175 - 185

13. A Quantitative Approach for Making Go/No-Go Decisions in Drug Development

    • Christy Chuang-Stein
    • Simon Kirby
    • Mohan Beltangady

    Biostatistics 01 March 2011 Pages: 187 - 202

14. Design and Size of Bioequivalence Studies for Inhaled Drugs

    • Anders Källén

    Biostatistics 01 March 2011 Pages: 203 - 207

15. Review of Methods and Measures for Using Existing Drug Information Material for Patient Information

    • Pratyush Lohani
    • Surinder Jeet Singh

    Book Review 01 March 2011 Pages: 209 - 211

16. 2011 EuroMeeting Student Poster Abstracts

    Euromeeting 01 March 2011 Pages: 213 - 219